Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 7
2005 5
2006 6
2007 2
2008 2
2009 2
2010 8
2011 4
2012 2
2013 3
2014 4
2015 3
2016 1
2017 7
2018 14
2019 4
2020 3
2021 15
2022 3
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Fujiwara T, Yakoub MA, Chandler A, Christ AB, Yang G, Ouerfelli O, Rajasekhar VK, Yoshida A, Kondo H, Hata T, Tazawa H, Dogan Y, Moore MAS, Fujiwara T, Ozaki T, Purdue E, Healey JH. Fujiwara T, et al. Among authors: yoshida a. Mol Cancer Ther. 2021 Aug;20(8):1388-1399. doi: 10.1158/1535-7163.MCT-20-0591. Epub 2021 Jun 4. Mol Cancer Ther. 2021. PMID: 34088832 Free PMC article.
Role of Tumor-Associated Macrophages in Sarcomas.
Fujiwara T, Healey J, Ogura K, Yoshida A, Kondo H, Hata T, Kure M, Tazawa H, Nakata E, Kunisada T, Fujiwara T, Ozaki T. Fujiwara T, et al. Among authors: yoshida a. Cancers (Basel). 2021 Mar 3;13(5):1086. doi: 10.3390/cancers13051086. Cancers (Basel). 2021. PMID: 33802565 Free PMC article. Review.
Intraoperative O-arm-navigated resection in musculoskeletal tumors.
Fujiwara T, Kunisada T, Takeda K, Hasei J, Nakata E, Nakahara R, Yoshida A, Ozaki T. Fujiwara T, et al. Among authors: yoshida a. J Orthop Sci. 2018 Nov;23(6):1045-1050. doi: 10.1016/j.jos.2018.06.012. Epub 2018 Jul 21. J Orthop Sci. 2018. PMID: 30037470
PRRX1 promotes malignant properties in human osteosarcoma.
Joko R, Yamada D, Nakamura M, Yoshida A, Takihira S, Takao T, Lu M, Sato K, Ito T, Kunisada T, Nakata E, Ozaki T, Takarada T. Joko R, et al. Among authors: yoshida a. Transl Oncol. 2021 Jan;14(1):100960. doi: 10.1016/j.tranon.2020.100960. Epub 2020 Dec 9. Transl Oncol. 2021. PMID: 33395745 Free PMC article.
Drug-induced linear IgA bullous dermatosis.
Onodera H, Mihm MC Jr, Yoshida A, Akasaka T. Onodera H, et al. Among authors: yoshida a. J Dermatol. 2005 Sep;32(9):759-64. doi: 10.1111/j.1346-8138.2005.tb00839.x. J Dermatol. 2005. PMID: 16361722 Review.
Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression.
Sugiu K, Tazawa H, Hasei J, Yamakawa Y, Omori T, Komatsubara T, Mochizuki Y, Kondo H, Osaki S, Fujiwara T, Yoshida A, Kunisada T, Ueda K, Urata Y, Kagawa S, Ozaki T, Fujiwara T. Sugiu K, et al. Among authors: yoshida a. Cancer Chemother Pharmacol. 2021 Sep;88(3):513-524. doi: 10.1007/s00280-021-04310-5. Epub 2021 Jun 10. Cancer Chemother Pharmacol. 2021. PMID: 34114067 Free article.
Bone engineering by phosphorylated-pullulan and β-TCP composite.
Takahata T, Okihara T, Yoshida Y, Yoshihara K, Shiozaki Y, Yoshida A, Yamane K, Watanabe N, Yoshimura M, Nakamura M, Irie M, Van Meerbeek B, Tanaka M, Ozaki T, Matsukawa A. Takahata T, et al. Among authors: yoshida a. Biomed Mater. 2015 Nov 20;10(6):065009. doi: 10.1088/1748-6041/10/6/065009. Biomed Mater. 2015. PMID: 26586655
96 results